OkayTake HLP Vitality Capsules

Founded by Million Wellness International Trading Co., Ltd., OkayTake partners with WAKi Pharmaceutical Co., Ltd. — a GMP-certified manufacturer in Nara, Japan — to develop exclusive formulas crafted entirely in Japan, from raw materials to finished product.

Key Formula Features WAKi's patented high-activity lumbrokinase (HLP) combined with methyl hesperidin, precisely formulated for consistent quality in every capsule.

Manufacturing Produced at WAKi's GMP-certified Nara facility with full quality control at every stage, verified by Japan's food analysis centers for safety and traceability.

Certifications SNQ National Quality Mark (No. P080035) · Monde Selection International Award · JIHFS Japan Health Food Standards · WAKi GMP Certification

Suggested Use Take 3–6 capsules daily with water. This product is a general food supplement, not a drug, and does not treat or prevent any disease. Maintain a balanced diet and exercise regularly."

GMP: WAKi Pharmaceutical Co., Ltd. — GMP Manufacturing Quality Certification

JIHFS: Japan Institute for Health Food Standards Certification

Monde Selection: International Quality Institute, Belgium (2024 Award Recipient)

Earthworm Dried Powder (containing Microcrystalline Cellulose), Methyl Hesperidin, Rhodiola Rosea Extract, L-Arginine, Turmeric, Potato Starch, Calcium Stearate, Gelatin, Water, Caramel Color

Per recommended daily serving (6 capsules), this product contains the following active ingredients:

① Dried Earthworm Powder (HLP High-Activity Lumbrokinase) — 25mg per capsule, 150mg per day

② Hesperidin — 20mg per capsule, 120mg per day

WAKI PHARMACEUTICAL CO., LTD.

This product is manufactured by WAKI PHARMACEUTICAL CO., LTD. at its GMP-certified facility in Nara Prefecture, Japan, under strict quality management protocols across three key stages: Incoming Material Inspection: All raw materials, including dried earthworm powder and hesperidin, are verified against composition specifications upon receipt. Non-conforming materials are rejected before entering production. In-Process Quality Control: Semi-finished products undergo sampling inspections covering capsule weight uniformity (250mg ±10%), appearance, seal integrity, and content uniformity, conducted in a controlled clean environment. Outgoing Product Inspection: Finished products are tested by an independent Japanese food analysis center prior to shipment, verifying active ingredient content, heavy metals, and microbiological safety. Each batch is traceable via unique lot numbers. Stability Management: Lot-based traceability, proper storage conditions, three-year shelf life management, and ongoing GMP and JIHFS certification maintenance ensure consistent product quality across all batches.

[SGS Taiwan Ltd.]

Microbiological testing

Heavy metal testing

Pharmaceutical residues screening (365 items)

Pesticide residues quantitative analysis (365 items)

[Ai-Zi-Wei Analytical Laboratory]

Proteolytic enzyme activity assay

Method: AGV-SOP-E105

Risk Management System Managed under Million Wellness International Trading Co., Ltd.'s Quality Management Regulations (Rev. A, 2021), the Management Department oversees a four-stage risk control mechanism:

[Incoming] WAKi Pharmaceutical provides batch inspection reports. Samples are SGS-tested for heavy metals and plasticizers upon arrival. Import documentation includes certificate of origin, composition specs, and Japanese food analysis center reports.

[Manufacturing] WAKi maintains Japan GMP certification with controls over raw material weighing, semi-finished sampling, and environmental monitoring. Lot numbers ensure full traceability. [Finished Product] Third-party testing by Japan's food analysis centers verifies ingredient content, heavy metals, microbiological safety, and pesticide residues before shipment. Records retained five years minimum.

[Post-Market] Consumer adverse reactions are monitored via hotline, email, and social media. Quality complaints trigger lot traceability and manufacturer corrective action reports. Recalls are executed by hazard level (L1: 3 days, L2: 7 days, L3: 10 days), authorized by internal management. All records retained five years minimum.